Skip to Main Content

Paper Details

Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.
Stroke
22
2022
Author NameAffiliation
Patrick YueFormer employee of Portola Pharmaceuticals
  • 1 - 1

Datasets

Release 1.2